Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses ( NEW ORLEANS March 26 2007 /PRNewswir...)

HOME >> MEDICINE >> TECHNOLOGY

Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses

NEW ORLEANS, March 26, 2007 /PRNewswire/ -- A large patient registry of "real world" uses for the CYPHER(R) Sirolimus-eluting Coronary Stent reported favorable safety and efficacy outcomes at two-year follow-up, according to clinical investigators at the of Cardiology's 56th Annual Scientific Session (ACC.07).

The MATRIX Registry is a prospective, single-arm study designed to evaluate the outcomes of percutaneous coronary intervention (PCI or balloon angioplasty) with the CYPHER(R) Stent in everyday medical practice out to five years. Sponsored by Cordis Corporation, the registry reports on clinical data from 1,522 consecutive patients in whom the CYPHER(R) Stent was implanted, including high percentages of complex patient populations that are not currently within the approved labeling, such as patients with diabetes (33.8 percent), or history of heart attack (33.4 percent), balloon angioplasty (44.6 percent) or bypass surgery (21 percent). Overall, 86 percent of the interventions involved a specific patient or lesion characteristic not currently within the approved labeling for the CYPHER(R) Stent, and would be considered "off-label."

"The MATRIX Registry provides invaluable information to help physicians assess the long-term safety of the CYPHER(R) Stent in 'real world' patient populations," said Principal Investigator George D. Dangas, M.D., Ph.D., Associate Professor of Medicine, The Cardiovascular Research Foundation/Columbia University Medical Center, who presented the results.

In spite of the overall patient and lesion complexity, the MATRIX Registry indicated low frequency of adverse events with the CYPHER(R) Stent throughout the two years of patient follow-up. Applying the Academic Research Consortium (ARC) definition of stent thrombosis, the investigators reported a 0.7 percent rate of definite stent thrombosis and a 1.1 percent rate of definite/probable stent thrombosis. Total mo
'"/>

Page: 1 2 3 4
Related medicine technology :

1. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
2. Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm Stents Positive Clinical Profile
3. Monitoring Patient Glucose Levels: New Advances in software make it easier
4. Managing Preanalytical Processes for Patient Safety
5. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
6. Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Post Your Comments:

(Date:6/19/2013)... YORK , June 19, 2013 /PRNewswire-iReach/ -- ... pioneer of modern hair transplant procedures and founder ... was included in the ,Best Doctors, issue of ... (Photo: http://photos.prnewswire.com/prnh/20130619/CG34629 ) ... Best Doctors issue, and his reputation as world-renowned ...

(Date:6/19/2013)... The American Association for Homecare (AAHomecare), along with ... , announced today the filing of a lawsuit ... , asking that the scheduled July 1 expansion of the ... be stopped because of serious licensing irregularities. The ... (HHS) Secretary Kathleen Sebelius as the defendant. HHS ...

(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... a new market research report is ... Partnerships, Licensing, Investments and M&A ... in Pharmaceuticals http://www.reportlinker.com/p0925641/Partnerships-Licensing-Investments-and-MA-Deals-and-Trends-for-May-2013-in-Pharmaceuticals.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Investment_Banking ... and M&A Deals and Trends for ...

[0] Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year [0] AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program [0] Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals

... New Data to be Presented at ASCO Shows Survival ... Partial Responders Compared with Chemotherapy ... (OTC Bulletin Board: GNTA) announced the results of long-term,followup ... oncology product,Genasense(R) (oblimersen sodium) Injection, in patients with chronic,lymphocytic ...

... Wyeth,Pharmaceuticals, a division of Wyeth (NYSE: WYE ... Administration (FDA) has granted Fast Track designation,to the ... toddlers. Wyeth is seeking a pediatric indication for,active ... caused by serotypes included in the vaccine. The ...

Cached Medicine Technology:Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 2 Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 3 Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 4 Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers 2 Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers 3 Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers 4

Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers

(Date:6/19/2013)... 2013 Brand new Hypertrophy Max bonus just released ... sale on the Hypertrophy Max program. Vince and Ben are ... those that are interested must act quickly. , What is the ... bonus is a free 12 month all access pass to the ... Ryan Davids "Live Large TV is a Monday night show where ...

(Date:6/19/2013)... Neb. (PRWEB) June 20, 2013 Author Byron ... give children a basic explanation of how the body’s defense ... Brownie Bill and the Health Pirates ” (published by Trafford ... and the Health Pirates” tells the story of Bobbie, a ... fever one morning. His mother takes him to visit Doctor ...

(Date:6/19/2013)... Colorado (PRWEB) June 19, 2013 Daily Gossip ... vertical jump training method will be published on their ... preview of the article to inform readers about the information ... declaration made by reporters working at Daily Gossip, the article ... Guide . , Hiller has understood during the vast ...

(Date:6/19/2013)... (PRWEB) June 19, 2013 PrettySkin4Less announces ... organic skin serums by top skin care manufacturer ... high concentrations of vitamins, minerals and active organic ingredients ... that so many other beauty products offer. For this ... lining up. , "I like products that do ...

(Date:6/19/2013)... UT (PRWEB) June 19, 2013 ... , In July 2013, Orriant is launching a ... rates, and maintain compliance with regulations. New ... to receive wellness incentives if their employer offers ... they have been compliant with these standards for ...

Breaking Medicine News(10 mins):Health News:New Hypertrophy Max Bonus Just Released and Only Available for 24 Hours 2 Health News:New Book Shows Children How the Body Fights Germs 2 Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2 Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2 Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2 Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3

[0] New Hypertrophy Max Bonus Just Released and Only Available for 24 Hours [0] New Book Shows Children How the Body Fights Germs [0] The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training [0] PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base [0] New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations

... common type of disorder in which the patient develops tingling and ... approved the drug to be sold to treat the disorder. It ... about 10% of the people are affected by this disorder. ... of now it is used to treat mild to moderate or ...

... here lawyers in California have sued PepsiCo alleging one of ... drink in question is Pepsi Twist drink, and it is ... firms has been drawn into a legal battle. ,Lawyers ... Twist has been falsely promoted as a safe consumer product, ...

... the anti-quota camp, the Supreme Court Friday reversed an ... seats on an all-India basis// for scheduled castes and ... 2006-07 academic year. ,A bench of judges K.G. ... of Additional Solicitor General Gopal Subramaniam that enforcing the ...

... of Orissa, declared that his health is normal. // The ... after he ran an astounding 65km earlier this week. ... Bhubaneswar for a medical check up on the orders of ... Biranchi Das was exploiting the boy for his personal gains. ...

... India (MCI) has condemned the poor infrastructure, lack lustre teaching ... // ,The (MCI) delegation, headed by Dr Lalita ... college and its failure to set up proper infrastructure over ... the college building was another factor of contention and a ...

... Lomb Inc. is in serious trouble after an eye infection ... its lens care products.// There are complaints arising from Asia, ... lens care products might be linked to a spate of ... a handful of cases of the infection had also been ...

Cached Medicine News:Health News:Supreme Court Quashed Reservation Quotas For PG Medical Courses 2 Health News:Marathon Kid Budhia’s Health Not Compromise 2

Mirapexin to Treat Restless Leg Syndrome Pepsi company in a lawsuit(soup)!Supreme Court Quashed Reservation Quotas For PG Medical Courses Marathon Kid Budhia’s Health Not Compromise Agartala Medical College under Fire from MCI Contact Lens Care Products Results In Eye Infection

Medpor 2/3 Orbit implants are designed to replace non load bearing bony structures in the orbital area....

... Orbital Rim implant can provide up to ... to be trimmed to meet the needs ... allows it to rest on the most ... flange allows easier positioning of the implant ...

Flattened points in vertical plane, straight shafts, cross action, round handle....

1.5 mm inner cutting edge....

Medicine Products:

MEDPOR 2/3 Orbit Complex MEDPOR Inferior Orbital Rims Akahoshi Prechop (12 o'clock approach)Appasamy Phaco Choppper